Krzysztof Brzozka
Directeur Technique/Scientifique/R&D chez RYVU THERAPEUTICS S.A.
Fortune : 4 M $ au 31/05/2024
Profil
Krzysztof Brzozka is currently the Director at Ardigen SA and the Chief Scientific Officer & Executive VP at Ryvu Therapeutics SA. He has a graduate degree from Uniwersytet Jagiellonski, a doctorate degree from Ludwig-Maximilians-Universität München, and MBA degrees from Cracow University of Economics and Stockholm Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
RYVU THERAPEUTICS SA
1,16% | 31/12/2022 | 267 321 ( 1,16% ) | 4 M $ | 31/05/2024 |
Postes actifs de Krzysztof Brzozka
| Sociétés | Poste | Début |
|---|---|---|
| RYVU THERAPEUTICS S.A. | Directeur Technique/Scientifique/R&D | 17/07/2014 |
Ardigen SA
 Ardigen SA Packaged SoftwareTechnology Services Ardigen SA is a precision medicine company based in Kraków, Poland. The Polish company specializes in using advanced artificial intelligence methods to accelerate therapy development by decoding microbiome, designing immunity, and providing digital drug discovery services. Ardigen's team has deep expertise in bioinformatics, machine learning, and software engineering, and their in-house datasets and platforms for immunology, biomarker, and microbiome research can empower effective pharmaceuticals development. The private company was founded by Pawel Przewiezlikowski, and the CEO is Janusz Homa. | Directeur/Membre du Conseil | - |
Formation de Krzysztof Brzozka
| Uniwersytet Jagiellonski | Graduate Degree |
| Ludwig-Maximilians-Universität München | Doctorate Degree |
| Cracow University of Economics | Masters Business Admin |
| Stockholm Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| RYVU THERAPEUTICS S.A. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Ardigen SA
Ardigen SA Packaged SoftwareTechnology Services Ardigen SA is a precision medicine company based in Kraków, Poland. The Polish company specializes in using advanced artificial intelligence methods to accelerate therapy development by decoding microbiome, designing immunity, and providing digital drug discovery services. Ardigen's team has deep expertise in bioinformatics, machine learning, and software engineering, and their in-house datasets and platforms for immunology, biomarker, and microbiome research can empower effective pharmaceuticals development. The private company was founded by Pawel Przewiezlikowski, and the CEO is Janusz Homa. | Technology Services |
